Lobe Sciences (TSE:LOBE) has released an update.
Lobe Sciences Ltd., a North American Biopharmaceutical Company, announced the results of its 2024 Annual General Meeting, where Fred Sancilio, Harry Jacobson, and Wesley Ramjeet were appointed to its board. Shareholders voted on key resolutions, including the re-appointment of the company’s auditor, Davidson LLP. The company is known for its focus on rare diseases and the development of psilocin-based compounds for neurological therapies.
For further insights into TSE:LOBE stock, check out TipRanks’ Stock Analysis page.
